Du N

No ORCID on file · 7 papers in corpus · active 2016-2026

Study types

  • other 2

Condition tags

  • endometriosis 2
2026
International journal of general medicine ·doi:10.2147/ijgm.s586914

BackgroundImmature teratoma is a malignant tumor and accounts for 1%-3% of ovary teratoma. The objective of this study was to find the potential single nucleotide polymorphisms (SNPs), copy number variations (CNVs) and drug targets in the i…

2025
Hereditas ·doi:10.1186/s41065-025-00540-2

BackgroundOvarian cancer has poor treatment outcomes. This study aims to explore the clinical importance of LINC00886 and its effects on cancer cell behavior in ovarian cancer, potentially offering a new therapeutic target.Materials and met…

other 2025
Gene ·doi:10.1016/j.gene.2025.149385

BACKGROUND: Emerging evidence suggests that aberrantly expressed microRNAs (miRNAs) participate in endometriosis pathogenesis. miR-1229-5p participates in the pathogenesis of several disease, but its precise role and mechanism in endometrio…

other 2024
Frontiers in immunology ·doi:10.3389/fimmu.2024.1507083

BACKGROUND: Ferroptosis, a recently discovered iron-dependent cell death, is linked to various diseases but its role in endometriosis is still not fully understood. METHODS: In this study, we integrated microarray data of endometriosis fro…

2023
BMC women's health ·doi:10.1186/s12905-023-02741-1

BackgroundIn the past, the primary treatment for MRKH syndrome (Mayer-Rokitansky-Küster-Hauser syndrome) with a functional primordial uterus was surgical removal of the functional primordial uterus. In rare instances, the endometrium of the…

2018
Cancer medicine ·doi:10.1002/cam4.1485

Leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5) plays a vital role in the development of malignant tumors; however, its biological role and underlying mechanism in epithelial ovarian cancer (EOC) remain unclear. In this s…

2016
Oncotarget ·doi:10.18632/oncotarget.8530

The lack of efficient tumor progression and chemoresistance indicators leads to high mortality in epithelial ovarian cancer (EOC) patients. Dysregulated miR-520g expression is involved in these processes in hepatic and colorectal cancers. I…